Treating Insomnia to Support Mental Health

Medically reviewed | Published: | Evidence level: 1A
Clinicians increasingly treat persistent insomnia as a modifiable health problem rather than only a symptom of another condition. Cognitive behavioral therapy for insomnia remains first-line care, while prescription medicines may help selected patients after clinicians assess benefits, risks and underlying sleep disorders.
📅 Published:
Reviewed by iMedic Medical Editorial Team
📄 Mental Health

Quick Facts

Adult Sleep Goal
At least 7 hours
First-Line Care
Cognitive behavioral therapy
FDA Boxed Warning
Three Z-drugs

Can Treating Insomnia Improve Mental Health?

Quick answer: Treating persistent insomnia can improve sleep and may also reduce symptoms such as low mood, anxiety and daytime distress.

Sleep and mental health influence each other in both directions. Depression, anxiety, trauma-related disorders and substance use can disrupt sleep, while prolonged insomnia can worsen emotional regulation, concentration and quality of life. Research summarized in medical journals, including Nature Medicine, supports evaluating sleep as a potential treatment target rather than assuming it will automatically improve when another condition is treated.

Cognitive behavioral therapy for insomnia, or CBT-I, combines approaches such as stimulus control, carefully managed time in bed, cognitive techniques and sleep-habit education. The American College of Physicians recommends CBT-I as initial treatment for adults with chronic insomnia. Evidence suggests that it can improve insomnia and provide additional mental-health benefits, but it does not replace established treatment for major depression, bipolar disorder or other psychiatric illnesses.

When Are Insomnia Medicines Appropriate?

Quick answer: Medicines may be considered when insomnia remains severe, CBT-I is unavailable or insufficient, and treatment risks have been individually assessed.

The American Academy of Sleep Medicine advises matching medication to the patient's main problem, such as difficulty falling asleep or repeated nighttime waking. Available options include dual orexin receptor antagonists and several older medicine classes. Selection should account for age, pregnancy, breathing disorders, liver function, other sedating medicines, substance-use history and the risk of next-day impairment.

Prescription sleep medicines are not interchangeable or risk-free. The US Food and Drug Administration requires boxed warnings for eszopiclone, zaleplon and zolpidem because rare complex sleep behaviors have caused serious injuries and deaths. Alcohol and other central nervous system depressants can increase sedation, while some medicines can cause falls, memory problems or impaired driving. Patients should use the lowest appropriate dose and seek medical advice before stopping a regularly used sedative because withdrawal or rebound insomnia may occur.

How Should Sleep Treatment Be Integrated Into Clinical Care?

Quick answer: Effective sleep treatment begins with identifying the cause, measuring symptoms and coordinating care with treatment for other medical or psychiatric conditions.

A clinical assessment should examine sleep timing, nighttime symptoms, medications, caffeine and alcohol use, work schedules and daytime impairment. Loud snoring, witnessed pauses in breathing or marked sleepiness may indicate obstructive sleep apnea, while uncomfortable leg sensations may suggest restless legs syndrome. Reduced need for sleep accompanied by unusually elevated energy or impulsivity requires prompt assessment for mania rather than routine insomnia treatment.

Progress can be followed with a sleep diary and validated insomnia questionnaire, focusing on daytime function as well as total sleep time. Digital CBT-I programs may expand access, although patients with complex psychiatric, neurologic or sleep disorders may need clinician-guided care. The emerging sleep-as-therapy model is therefore best understood as coordinated, diagnosis-based treatment—not a claim that sleeping longer can cure every illness.

Frequently Asked Questions

No. Sleep hygiene is only one component. CBT-I is a structured treatment that may include stimulus control, cognitive techniques and carefully adjusting time in bed.

Regular use should be discussed with a clinician or pharmacist. Some products can cause next-day sedation, confusion, constipation, urinary problems or drug interactions, particularly in older adults.

No medication should be stopped solely because sleep improves. Antidepressants and other psychiatric medicines require an individualized review, and abrupt discontinuation can cause withdrawal symptoms or relapse.

References

  1. Nature Medicine. Sleep as therapy. 2026.
  2. Qaseem A, Kansagara D, Forciea MA, Cooke M, Denberg TD. Management of Chronic Insomnia Disorder in Adults: A Clinical Practice Guideline From the American College of Physicians. Annals of Internal Medicine. 2016.
  3. Sateia MJ, Buysse DJ, Krystal AD, Neubauer DN, Heald JL. Clinical Practice Guideline for the Pharmacologic Treatment of Chronic Insomnia in Adults. Journal of Clinical Sleep Medicine. 2017.
  4. US Food and Drug Administration. FDA adds Boxed Warning for risk of serious injuries caused by sleepwalking with certain prescription insomnia medicines. 2019.
  5. Watson NF, Badr MS, Belenky G, et al. Recommended Amount of Sleep for a Healthy Adult: A Joint Consensus Recommendation of the American Academy of Sleep Medicine and Sleep Research Society. Sleep. 2015.